
    
      Fifty-three, fibromyalgia syndrome participants were randomized to receive either: 1)
      probiotic 4Ã—1010 CFUs per day 2) 10 g dose prebiotic (inulin) per day or 3) placebo for 8 wk.
      Fibromyalgia Impact Questionnaire (FIQ), Visual Analogical Pain Scale (VAS), Beck Depression
      Inventory (BDI), Beck Anxiety Inventory (BAI), Pittsburg Sleep Quality Index (PSQI) and
      quality of life (SF-36) were measured during the baseline, 4 weeks and 8 weeks intervention
      phases. Finally, the adverse effects will be evaluated.
    
  